Selected References
- Blandthorn J, et al. 2018. Managing opioid overdose in pregnancy with take-home naloxone. Aust N Z J Obstet Gyneacol 58(4):460-62.
- Gawronski KM, et al. 2014. Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone. 2:2050312114530282.
- Jones HE & Kraft WK. 2019. Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome. Clin Perinatol; 46(2):349-366.
- Jumah NA, et al. 2016. Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population. BMJ Open; 6(10):e011774.
- Debelak K, et al. 2013. Buprenorphine + Naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. Am J Addict; 22(3):252-54.
- Hale TW & Rowe HE. 2017. Medications & Mother’s Milk, Seventeenth Edition. Springer Publishing Co.
- Mitchell C, et al. 2020. Management of dependent use of illicit opioids. BMJ 368:m710. doi: 10.1136/bmj.m710.
- Nguyen L, et al. 2018. Treating Women with Opioid Use Disorder during Pregnancy in Appalachia: Initial Neonatal Outcomes Following Buprenorphine+Naloxone Exposure. Am J Addict 27(2):92-96.
- Preston KL, et al. 1990. Effects of sublingually given naloxone in opioid-dependent human volunteers. Drug Alcohol Depend 25(1):27-34.
- Wiegand SL, et al. 2016. Naloxone and Metabolites Quantification in cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations. AJP 6(4)e385-90.
- Zelner I, et al. 2015. Acute Poisoning During Pregnancy: Observations from the Toxicology Investigators Consortium. J Med Toxicol 11(3):301-08.
